Breast Cancer

News and reporting on breast cancer.

Jun 24, 2022

Paige Gets CE-IVD Mark, UK Regulatory Approval for Breast Cancer Biomarker Software

Jun 22, 2022

Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer
Premium

Jun 9, 2022

Morgan and Mendel Genomics Developing Diagnostic Tests for Cancer-Related Variant Detection
Premium

Jun 8, 2022

New Data Suggests Liquid Biopsy Provides Early ID of Breast Cancer Patients Destined to Recur
Premium

Jun 1, 2022

Epic Sciences Raises $43M in Series F Round

May 31, 2022

BCAL Looks to Commercialize Breast Cancer Lipid Assay in US, Beyond
Premium

May 25, 2022

Aiforia Gains CE-IVD Mark for Breast Cancer AI Model

May 25, 2022

Angle Gets FDA Clearance for Breast Cancer Cell Isolation System

Apr 18, 2022

AmoyDx, AstraZeneca Collaborate to Develop, Commercialize Companion Diagnostic Tests

Apr 8, 2022

Consortium Developing Evidence to Integrate Analytic Standards, Improve Comparability of IHC Assays
Premium

Apr 6, 2022

Paige Nabs CE Mark, UK Regulatory Approval for Breast Cancer AI Tool

Mar 22, 2022

Precision Medicine Firm PreludeDx Closes $20M Funding Round

Mar 11, 2022

FDA Approves Lynparza as Adjuvant Therapy With Myriad Genetics CDx for BRCA-Mutated Breast Cancer

Mar 9, 2022

Reveal Genomics Introduces HER2DX Breast Cancer Test in Europe, Plans US Expansion
Premium

Feb 23, 2022

Cerca Biotech Inks European Distribution Deals for MammaTyper Breast Cancer Subtyping Test

Feb 15, 2022

Paige, Mindpeak Strike Distribution Deal for Digital Pathology Technologies

Jan 27, 2022

Agendia Offering AI-Enabled Genomic Test for Breast Cancer in Brazil as it Eyes Global Market
Premium

Jan 26, 2022

German Firm Mindpeak Using AI-Based Deep Learning to Automate Digital Pathology
Premium

Dec 21, 2021

Biocept to Refocus CNSide Assay Plans After FDA Feedback Suggests Targeting Narrower Indications
Premium

Dec 17, 2021

Test Measuring Skin's Electrical Conductivity Could Be Used as Tool for Breast Cancer Dx
Premium